{
  "study_id": "NCT00066690",
  "study_title": "Adjuvant Ovarian Suppression in Premenopausal Breast Cancer",
  "table_name": "Table 1",
  "table_title": "Characteristics of Patients in the Primary Analysis, Overall and According to Chemotherapy Cohort.",
  "footnotes": [
    "A more complete summary is provided in Table S1 in the Supplementary Appendix. Characteristics were well balanced according to treatment assignment (Table S2 in the Supplementary Appendix). The statistical analysis plan did not specify hypothesis testing regarding comparisons between these groups. HER2 denotes human epidermal growth factor receptor 2.",
    "Data were missing for 7 patients who did not receive chemotherapy and for 45 who had received chemotherapy previously.",
    "Data were missing for 12 patients who did not receive chemotherapy and for 36 who had received chemotherapy previously.",
    "Oral endocrine therapy before randomization was allowed while premenopausal status was established or reestablished."
  ],
  "groups": [
    {
      "name": "No Chemotherapy",
      "n": 949
    },
    {
      "name": "Prior Chemotherapy",
      "n": 1084
    },
    {
      "name": "Overall",
      "n": 2033
    }
  ],
  "characteristics": [
    {
      "original_label": "Age at randomization",
      "standardized_name": "Age",
      "category": "Demographics",
      "time_point": "At randomization",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "No Chemotherapy",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "Prior Chemotherapy",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "Overall",
          "data_type": "header",
          "raw_string": ""
        }
      ]
    },
    {
      "original_label": "Median — yr",
      "standardized_name": "Age, Median",
      "unit": "years",
      "category": "Demographics",
      "time_point": "At randomization",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Age at randomization",
      "group_data": [
        {
          "group_name": "No Chemotherapy",
          "data_type": "numeric_single",
          "value": 46.0,
          "raw_string": "46"
        },
        {
          "group_name": "Prior Chemotherapy",
          "data_type": "numeric_single",
          "value": 40.0,
          "raw_string": "40"
        },
        {
          "group_name": "Overall",
          "data_type": "numeric_single",
          "value": 43.0,
          "raw_string": "43"
        }
      ]
    },
    {
      "original_label": "<35 yr",
      "standardized_name": "Age < 35 years",
      "category": "Demographics",
      "time_point": "At randomization",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Age at randomization",
      "group_data": [
        {
          "group_name": "No Chemotherapy",
          "data_type": "categorical_count_percentage",
          "count": 14.0,
          "percentage": 1.5,
          "raw_string": "14 (1.5)"
        },
        {
          "group_name": "Prior Chemotherapy",
          "data_type": "categorical_count_percentage",
          "count": 219.0,
          "percentage": 20.2,
          "raw_string": "219 (20.2)"
        },
        {
          "group_name": "Overall",
          "data_type": "categorical_count_percentage",
          "count": 233.0,
          "percentage": 11.5,
          "raw_string": "233 (11.5)"
        }
      ]
    },
    {
      "original_label": "35–39 yr",
      "standardized_name": "Age 35-39 years",
      "category": "Demographics",
      "time_point": "At randomization",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Age at randomization",
      "group_data": [
        {
          "group_name": "No Chemotherapy",
          "data_type": "categorical_count_percentage",
          "count": 78.0,
          "percentage": 8.2,
          "raw_string": "78 (8.2)"
        },
        {
          "group_name": "Prior Chemotherapy",
          "data_type": "categorical_count_percentage",
          "count": 309.0,
          "percentage": 28.5,
          "raw_string": "309 (28.5)"
        },
        {
          "group_name": "Overall",
          "data_type": "categorical_count_percentage",
          "count": 387.0,
          "percentage": 19.0,
          "raw_string": "387 (19.0)"
        }
      ]
    },
    {
      "original_label": "40–49 yr",
      "standardized_name": "Age 40-49 years",
      "category": "Demographics",
      "time_point": "At randomization",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Age at randomization",
      "group_data": [
        {
          "group_name": "No Chemotherapy",
          "data_type": "categorical_count_percentage",
          "count": 702.0,
          "percentage": 74.0,
          "raw_string": "702 (74.0)"
        },
        {
          "group_name": "Prior Chemotherapy",
          "data_type": "categorical_count_percentage",
          "count": 522.0,
          "percentage": 48.2,
          "raw_string": "522 (48.2)"
        },
        {
          "group_name": "Overall",
          "data_type": "categorical_count_percentage",
          "count": 1224.0,
          "percentage": 60.2,
          "raw_string": "1224 (60.2)"
        }
      ]
    },
    {
      "original_label": "≥50 yr",
      "standardized_name": "Age >= 50 years",
      "category": "Demographics",
      "time_point": "At randomization",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Age at randomization",
      "group_data": [
        {
          "group_name": "No Chemotherapy",
          "data_type": "categorical_count_percentage",
          "count": 155.0,
          "percentage": 16.3,
          "raw_string": "155 (16.3)"
        },
        {
          "group_name": "Prior Chemotherapy",
          "data_type": "categorical_count_percentage",
          "count": 34.0,
          "percentage": 3.1,
          "raw_string": "34 (3.1)"
        },
        {
          "group_name": "Overall",
          "data_type": "categorical_count_percentage",
          "count": 189.0,
          "percentage": 9.3,
          "raw_string": "189 (9.3)"
        }
      ]
    },
    {
      "original_label": "Lymph-node status — no. (%)",
      "standardized_name": "Lymph Node Status",
      "category": "Disease Characteristics",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "No Chemotherapy",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "Prior Chemotherapy",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "Overall",
          "data_type": "header",
          "raw_string": ""
        }
      ]
    },
    {
      "original_label": "Negative",
      "standardized_name": "Lymph Node Status, Negative",
      "category": "Disease Characteristics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Lymph-node status — no. (%)",
      "group_data": [
        {
          "group_name": "No Chemotherapy",
          "data_type": "categorical_count_percentage",
          "count": 861.0,
          "percentage": 90.7,
          "raw_string": "861 (90.7)"
        },
        {
          "group_name": "Prior Chemotherapy",
          "data_type": "categorical_count_percentage",
          "count": 463.0,
          "percentage": 42.7,
          "raw_string": "463 (42.7)"
        },
        {
          "group_name": "Overall",
          "data_type": "categorical_count_percentage",
          "count": 1324.0,
          "percentage": 65.1,
          "raw_string": "1324 (65.1)"
        }
      ]
    },
    {
      "original_label": "Positive",
      "standardized_name": "Lymph Node Status, Positive",
      "category": "Disease Characteristics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Lymph-node status — no. (%)",
      "group_data": [
        {
          "group_name": "No Chemotherapy",
          "data_type": "categorical_count_percentage",
          "count": 88.0,
          "percentage": 9.3,
          "raw_string": "88 (9.3)"
        },
        {
          "group_name": "Prior Chemotherapy",
          "data_type": "categorical_count_percentage",
          "count": 621.0,
          "percentage": 57.3,
          "raw_string": "621 (57.3)"
        },
        {
          "group_name": "Overall",
          "data_type": "categorical_count_percentage",
          "count": 709.0,
          "percentage": 34.9,
          "raw_string": "709 (34.9)"
        }
      ]
    },
    {
      "original_label": "Tumor size — no. (%)",
      "standardized_name": "Tumor Size",
      "category": "Disease Characteristics",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "No Chemotherapy",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "Prior Chemotherapy",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "Overall",
          "data_type": "header",
          "raw_string": ""
        }
      ]
    },
    {
      "original_label": "<2 cm",
      "standardized_name": "Tumor Size < 2 cm",
      "unit": "cm",
      "category": "Disease Characteristics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Tumor size — no. (%)",
      "group_data": [
        {
          "group_name": "No Chemotherapy",
          "data_type": "categorical_count_percentage",
          "count": 806.0,
          "percentage": 84.9,
          "raw_string": "806 (84.9)"
        },
        {
          "group_name": "Prior Chemotherapy",
          "data_type": "categorical_count_percentage",
          "count": 526.0,
          "percentage": 48.5,
          "raw_string": "526 (48.5)"
        },
        {
          "group_name": "Overall",
          "data_type": "categorical_count_percentage",
          "count": 1332.0,
          "percentage": 65.5,
          "raw_string": "1332 (65.5)"
        }
      ]
    },
    {
      "original_label": "≥2 cm",
      "standardized_name": "Tumor Size >= 2 cm",
      "unit": "cm",
      "category": "Disease Characteristics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Tumor size — no. (%)",
      "group_data": [
        {
          "group_name": "No Chemotherapy",
          "data_type": "categorical_count_percentage",
          "count": 136.0,
          "percentage": 14.3,
          "raw_string": "136 (14.3)"
        },
        {
          "group_name": "Prior Chemotherapy",
          "data_type": "categorical_count_percentage",
          "count": 513.0,
          "percentage": 47.3,
          "raw_string": "513 (47.3)"
        },
        {
          "group_name": "Overall",
          "data_type": "categorical_count_percentage",
          "count": 649.0,
          "percentage": 31.9,
          "raw_string": "649 (31.9)"
        }
      ]
    },
    {
      "original_label": "Tumor grade — no. (%)",
      "standardized_name": "Tumor Grade",
      "category": "Disease Characteristics",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "No Chemotherapy",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "Prior Chemotherapy",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "Overall",
          "data_type": "header",
          "raw_string": ""
        }
      ]
    },
    {
      "original_label": "1",
      "standardized_name": "Tumor Grade 1",
      "category": "Disease Characteristics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Tumor grade — no. (%)",
      "group_data": [
        {
          "group_name": "No Chemotherapy",
          "data_type": "categorical_count_percentage",
          "count": 389.0,
          "percentage": 41.0,
          "raw_string": "389 (41.0)"
        },
        {
          "group_name": "Prior Chemotherapy",
          "data_type": "categorical_count_percentage",
          "count": 151.0,
          "percentage": 13.9,
          "raw_string": "151 (13.9)"
        },
        {
          "group_name": "Overall",
          "data_type": "categorical_count_percentage",
          "count": 540.0,
          "percentage": 26.6,
          "raw_string": "540 (26.6)"
        }
      ]
    },
    {
      "original_label": "2",
      "standardized_name": "Tumor Grade 2",
      "category": "Disease Characteristics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Tumor grade — no. (%)",
      "group_data": [
        {
          "group_name": "No Chemotherapy",
          "data_type": "categorical_count_percentage",
          "count": 483.0,
          "percentage": 50.9,
          "raw_string": "483 (50.9)"
        },
        {
          "group_name": "Prior Chemotherapy",
          "data_type": "categorical_count_percentage",
          "count": 523.0,
          "percentage": 48.2,
          "raw_string": "523 (48.2)"
        },
        {
          "group_name": "Overall",
          "data_type": "categorical_count_percentage",
          "count": 1006.0,
          "percentage": 49.5,
          "raw_string": "1006 (49.5)"
        }
      ]
    },
    {
      "original_label": "3",
      "standardized_name": "Tumor Grade 3",
      "category": "Disease Characteristics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Tumor grade — no. (%)",
      "group_data": [
        {
          "group_name": "No Chemotherapy",
          "data_type": "categorical_count_percentage",
          "count": 65.0,
          "percentage": 6.8,
          "raw_string": "65 (6.8)"
        },
        {
          "group_name": "Prior Chemotherapy",
          "data_type": "categorical_count_percentage",
          "count": 374.0,
          "percentage": 34.5,
          "raw_string": "374 (34.5)"
        },
        {
          "group_name": "Overall",
          "data_type": "categorical_count_percentage",
          "count": 439.0,
          "percentage": 21.6,
          "raw_string": "439 (21.6)"
        }
      ]
    },
    {
      "original_label": "HER2-positive — no. (%)",
      "standardized_name": "HER2 Positive Status",
      "category": "Disease Characteristics",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "No Chemotherapy",
          "data_type": "categorical_count_percentage",
          "count": 40.0,
          "percentage": 4.2,
          "raw_string": "40 (4.2)"
        },
        {
          "group_name": "Prior Chemotherapy",
          "data_type": "categorical_count_percentage",
          "count": 196.0,
          "percentage": 18.1,
          "raw_string": "196 (18.1)"
        },
        {
          "group_name": "Overall",
          "data_type": "categorical_count_percentage",
          "count": 236.0,
          "percentage": 11.6,
          "raw_string": "236 (11.6)"
        }
      ]
    },
    {
      "original_label": "Interval from surgery to randomization — mo",
      "standardized_name": "Interval from surgery to randomization",
      "unit": "months",
      "category": "Treatment Details",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "No Chemotherapy",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "Prior Chemotherapy",
          "data_type": "header",
          "raw_string": ""
        },
        {
          "group_name": "Overall",
          "data_type": "header",
          "raw_string": ""
        }
      ]
    },
    {
      "original_label": "Median",
      "standardized_name": "Interval from surgery to randomization, Median",
      "unit": "months",
      "category": "Treatment Details",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Interval from surgery to randomization — mo",
      "group_data": [
        {
          "group_name": "No Chemotherapy",
          "data_type": "numeric_single",
          "value": 1.8,
          "raw_string": "1.8"
        },
        {
          "group_name": "Prior Chemotherapy",
          "data_type": "numeric_single",
          "value": 8.0,
          "raw_string": "8.0"
        },
        {
          "group_name": "Overall",
          "data_type": "numeric_single",
          "value": 3.2,
          "raw_string": "3.2"
        }
      ]
    },
    {
      "original_label": "Interquartile range",
      "standardized_name": "Interval from surgery to randomization, IQR",
      "unit": "months",
      "category": "Treatment Details",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Interval from surgery to randomization — mo",
      "group_data": [
        {
          "group_name": "No Chemotherapy",
          "data_type": "numeric_median_iqr",
          "iqr_min": 1.2,
          "iqr_max": 2.4,
          "raw_string": "1.2–2.4"
        },
        {
          "group_name": "Prior Chemotherapy",
          "data_type": "numeric_median_iqr",
          "iqr_min": 5.8,
          "iqr_max": 10.3,
          "raw_string": "5.8–10.3"
        },
        {
          "group_name": "Overall",
          "data_type": "numeric_median_iqr",
          "iqr_min": 1.7,
          "iqr_max": 8.33,
          "raw_string": "1.7–8.33"
        }
      ]
    },
    {
      "original_label": "Endocrine therapy before randomization — no. (%)",
      "standardized_name": "Endocrine therapy before randomization",
      "category": "Treatment Details",
      "time_point": "Before randomization",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "No Chemotherapy",
          "data_type": "categorical_count_percentage",
          "count": 47.0,
          "percentage": 5.0,
          "raw_string": "47 (5.0)"
        },
        {
          "group_name": "Prior Chemotherapy",
          "data_type": "categorical_count_percentage",
          "count": 475.0,
          "percentage": 43.8,
          "raw_string": "475 (43.8)"
        },
        {
          "group_name": "Overall",
          "data_type": "categorical_count_percentage",
          "count": 522.0,
          "percentage": 25.7,
          "raw_string": "522 (25.7)"
        }
      ]
    }
  ]
}